The MarketReader Minute
π Ascendis, United Therapeutics Rise on Trial Data and FDA Catalyst | Biotech Sector Insights
IBB rose nearly 2% as gains in Amgen, Moderna, and Vertex lifted the sector, with easing geopolitical tensions and falling oil prices supporting risk sentiment.